GlassScriptPhysician profile
Peter Jeffrey Bechtel
NPI 1144481383
$2,499.16
in general payments reported to CMS, 2019-2025
28 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,440 · 2020: $34.28 · 2022: $80.38 · 2023: $516 · 2024: $283 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644 · Travel and Lodging: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.87 |
| Travel and Lodging | $300.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,035.40 | 2019-2024 | |
| Apollo Endosurgery US INC | $350.88 | 2023 | Overstitch Endoscopic Suturing System |
| Medical Device Business Services, INC. | $297.13 | 2019 | |
| Enterra Medical, INC. | $171.22 | 2023-2025 | |
| Becton, Dickinson and Company | $88.84 | 2024 | |
| Polynovo North America LLC | $54.98 | 2024 | Novosorb Btm |
| Smith+Nephew, INC. | $51.51 | 2019-2024 | Stravix |
| Heron Therapeutics, INC. | $36.17 | 2022 | |
| Lemaitre Vascular, INC. | $33.72 | 2019-2020 | |
| Baxter Healthcare | $32.65 | 2023 | Seprafilm |
| Ethicon US, LLC | $30.73 | 2019 | |
| Tela Bio, INC. | $30.29 | 2024 | Ovitex 2s |
| Axonics, INC. | $29.10 | 2024 | Bulkamid, Axonics |
| Merck Sharp & Dohme LLC | $24.97 | 2023 | Keytruda |
| Abbvie INC. | $22.21 | 2023 | Dalvance |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $22.00 | 2023 | |
| Jazz Pharmaceuticals INC. | $19.58 | 2023 | |
| Portola Pharmaceuticals, LLC | $18.52 | 2019 | |
| Kci USA, INC. | $18.21 | 2023 | V.A.C.Ulta, Prevena |
| Misonix INC | $15.60 | 2020 | |
| Solventum Corporation | $15.21 | 2024 | V.A.C. Veraflo, Prevena |
| Boston Scientific Corporation | $14.94 | 2022 | |
| Osiris Therapeutics INC. | $14.78 | 2019 | |
| Merit Medical Systems INC | $14.66 | 2024 | Savi Scout |
| Bioventus LLC | $14.65 | 2022 | |
| Hologic INC | $14.62 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.44 | 2019 | |
| Eisai INC. | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bechtel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.